𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics

✍ Scribed by Manfred Gerlach; Walter Maetzler; Karl Broich; Harald Hampel; Lucas Rems; Torsten Reum; Peter Riederer; Albrecht Stöffler; Johannes Streffer; Daniela Berg

Publisher
Springer
Year
2011
Tongue
English
Weight
246 KB
Volume
119
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of Parkinson's Disease in ent
Evaluation of Parkinson's Disease in entrants on the Nebraska State Parkinson's Disease Registry
✍ John M. Bertoni; Pamela M. Sprenkle; Daniel Strickland; Nancy Noedel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

## Abstract We examined a sample of individuals in the Nebraska State Parkinson's Disease Registry (NSPDR) to determine what proportion meets standard criteria for Parkinson's disease (PD). The NSPDR was established in 1996 in an effort to understand the high prevalence of PD in Nebraska. Only mini

Stem cells in development of therapeutic
Stem cells in development of therapeutics for Parkinson's disease: A perspective
✍ Jiajie Xi; Su-Chun Zhang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

## Abstract Using Parkinson's disease as a prototype of neurodegenerative diseases, we propose applications of human stem cells in the development of therapeutics for neurodegenerative diseases. First, in vitro differentiation of human stem cells offers a versatile model for dissecting molecular in

Rating impairment and disability in Park
Rating impairment and disability in Parkinson's disease: Evaluation of the unified Parkinson's disease rating scale
✍ Dr. J. J. van Hilten; A. D. van der Zwan; A. H. Zwinderman; R. A. C. Roos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

## Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to monitor disease progression and drug efficacy, no attempts have been made to evaluate its scientific and clinical quality. Poor clinical sensibility of items in the activities of daily living (ADL) section a

Functional organization of the basal gan
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
✍ Jose A. Obeso; Maria Cruz Rodríguez-Oroz; Beatriz Benitez-Temino; Franscisco J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

The basal ganglia (BG) are a highly organized network, where different parts are activated for specific functions and circumstances. The BG are involved in movement control, as well as associative learning, planning, working memory, and emotion. We concentrate on the ''motor circuit'' because it is